经尿道同期电切膀胱移行细胞癌合前列腺增生疗效的回顾性分析

Retrospective analysis of transurethral resection for transitional cell carcinoma of the bladder complicated with benign prostate hyperplasia

目的评价膀胱移行细胞癌(transitional cell carcinoma,TCC)合并前列腺增生采取同期经尿道电切治疗的疗效。方法将患者随机分为A、B组,A组26例实施单纯经尿道电切膀胱移行细胞癌,B组20例实施经尿道同期电切膀胱移行细胞癌及增生的前列腺,比较术后A、B组间复发时间、复发率、进展率、复发部位的差异。结果所有患者随访12~48月。A、B组术后肿瘤复发时间、复发率、进展率、复发部位的比较差异无统计学意义(P>0.05)。结论膀胱移行细胞癌合并前列腺增生实施同期经尿道电切术是可行的,与单纯电切膀胱移行细胞癌相比并不增加肿瘤的复发。

Objective To evaluate the effect of simultaneous transurethral resection of bladder tumor(TURBT) and benign prostatic hyperplasia(TURP) for transitional cell carcinoma of the bladder complicated with benign prostatic hyperplasia(BPH).Methods The patients were divided into two groups.Twenty-six cases in group A received TURBT,and 20 cases in group B received both TURBT and TURBT at the same operation.The recurrence and progression rate,relapse time,the recurrence rate in the bladder neck and prostatic urethra were compared between two groups.Results The patients were followed up for 12-48 months.No statistically significant differences were found between group A and group B in terms of follow-up time,recurrence,progression,recurrence in the prostatic urethra and / or bladder neck and relapse time(P >0.05).Conclusions combined therapy of TURBT and TURP for transitional cell carcinoma of the bladder complicated with BPH is feasible,and the recurrence is not raised compared with TURBT alone for transitional cell carcinoma of the bladder.